Vanguard Global Advisers
IRWD icon

Vanguard Global Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Vanguard Global Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.22M Sell
559,758
-1,280
-0.2% -$5.34K ﹤0.01% 1179
2026
Q2 		$2.36M Sell
561,038
-30,451
-5% -$117K ﹤0.01% 1148
2026
Q1 		$2.08M Buy
+591,489
New +$2.42M ﹤0.01% 1170

Other funds holding IRWD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Vanguard Global Advisers's IRWD Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Ironwood Pharmaceuticals (IRWD) stake by 0.23% in Q3 2026, selling an estimated $5.34K and leaving 559,758 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Vanguard Global Advisers first reported a position in IRWD in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.36M in Q2 2026. 176 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Vanguard Global Advisers held 559,758 shares of Ironwood Pharmaceuticals worth $2.22M as of Q3 2026.
  • Vanguard Global Advisers sold 1,280 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $5.34K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1179 holding.
  • Vanguard Global Advisers first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Ironwood Pharmaceuticals position peaked at $2.36M in Q2 2026.
  • 176 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.